Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients
Overview
Authors
Affiliations
Purpose: aim of this study was to identify outcomes in pain relief and quality of life in patients with a solitary painful osseous metastasis treated by radiotherapy, cryoablation or the combination using a propensity score matching study design.
Materials And Methods: 175 patients with painful bone metastases were included in the study. Twenty-five of them underwent a radiation course (20 Gy in five daily fractions) 15 days after the cryoablation. These subjects were retrospectively matched by propensity analysis with a group of subjects treated by radiotherapy (125 subjects) and with a group treated byCryoablation (25 subjects). The pain relief in terms of complete response, rate of subjects requiring analgesics after treatments and the changes in self-rated quality of life were measured. Informed consent was obtained from the subject and the study was approved by the local Ethical Committee.
Results: An higher proportion of subjects treated by cryoablation (32%) or cryoablation followed by RT (72%;) experienced a complete response compared with patients treated by radiotherapy alone (11.2%). After Bonferroni correction strategy, the addition of radiotherapy to cryoablation significantly improved the rate of complete response compared with cryoablation alone (p = 0.011) and this paralleled with an improved self-rated quality of life. Seventeen subjects (13.6%) of patients in the radiotherapy group, 9 (36%) in the cryoablation group, and 19 (76)% in the cryoablation- radiotherapy group did not require narcotic medications.
Conclusions: The addition of radiotherapy to cryoablation favorably impacts on perceived pain, with a favorable toxicity profile. However, our data should be interpreted with caution and could serve as a framework around which to design future trials.
Vizzuso A, Renzulli M, Lancellotta V, Posa A, Cornacchione P, Fionda B Cancers (Basel). 2025; 16(24.
PMID: 39766082 PMC: 11674161. DOI: 10.3390/cancers16244183.
Papalexis N, Savarese L, Peta G, Errani C, Tuzzato G, Spinnato P Curr Oncol. 2023; 30(7):6744-6770.
PMID: 37504355 PMC: 10377811. DOI: 10.3390/curroncol30070495.
Direct and indirect damage zone of radiofrequency ablation in porcine lumbar vertebra.
Zhang C, Feng J, Liu Y, Zhang Y, Song W, Ma Y Front Oncol. 2023; 13:1138837.
PMID: 36910648 PMC: 9992792. DOI: 10.3389/fonc.2023.1138837.
Cryoablation for the Palliation of Painful Bone Metastasis: A Systematic Review.
Khanmohammadi S, Noroozi A, Yekaninejad M, Rezaei N Cardiovasc Intervent Radiol. 2023; 46(11):1469-1482.
PMID: 36631660 DOI: 10.1007/s00270-022-03356-z.
Interventional Radiology in the Management of Metastases and Bone Tumors.
Sgalambro F, Zugaro L, Bruno F, Palumbo P, Salducca N, Zoccali C J Clin Med. 2022; 11(12).
PMID: 35743336 PMC: 9225477. DOI: 10.3390/jcm11123265.